WASHINGTON — Health Secretary Robert F. Kennedy Jr. and several high-ranking officials are set to engage with biotech leaders and health activists at the MAHA Summit, an event shrouded in secrecy and not publicly disclosed by administration officials. Scheduled for Wednesday at the prestigious Waldorf Astoria Hotel, the summit will feature key figures from federal health agencies, including CMS Administrator Mehmet Oz and FDA Commissioner Marty Makary.
The agenda promises discussions on critical topics such as the future of the FDA and NIH, advancements in artificial intelligence within healthcare, and the evolving landscape of biotech development. Attendees will have the opportunity for exclusive networking with these influential leaders, highlighting the summit’s significance in shaping health policy and industry trends. This gathering underscores the growing intersection of government and biotech, raising implications for regulatory frameworks and innovation strategies in the pharmaceutical sector.
Start your 7-day trial and see what the database can do →
